Nanotechnology's Significance In The Treatment Of Viral Illness And Their Future Prospective With Emerging Patents

The potential benefits and drawbacks of nanotechnology in viral therapy are like two sides of a coin. Many illnesses may now be better understood and treated with the help of nanomaterials. Lung cancer, TB, pulmonary fibrosis, and many more disorders can be treated with drug delivery systems based on nanoparticles. The primary killer on a global scale is infectious illnesses. Furthermore, there is a significant risk to public health from the adverse consequences of long-term usage and the fast development of drug resistance to existing therapies. Consequently, it is critical to find new therapeutic options. Diagnostics and treatment are two areas that stand to gain greatly from the ways in which nanostructures interact with diseases. An ideal vehicle for medication delivery would be nanoparticles due to their one-of-a-kind physicochemical characteristics. Properties such as a large drug payload capacity, an appropriate surface charge that can encapsulate, a high surface area to volume ratio that improves solubility relative to bigger particles, and a small particle size influence bioavailability and circulation time. In this article, we will take a look at how different nanotechnologies are being used to treat common viral diseases.